BioSyent Inc.
RX.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 19.41% | 16.12% | 21.47% | 18.18% | 11.99% |
| Total Depreciation and Amortization | 170.76% | 82.84% | 60.73% | 174.56% | 127.19% |
| Total Amortization of Deferred Charges | -200.36% | -211.79% | -222.14% | -107.92% | -75.63% |
| Total Other Non-Cash Items | -7.06% | -117.50% | 151.08% | 130.26% | 127.90% |
| Change in Net Operating Assets | -117.21% | 249.51% | -189.58% | -1,456.38% | 165.43% |
| Cash from Operations | -5.39% | 75.86% | 3.26% | 19.19% | 359.72% |
| Capital Expenditure | 24.48% | 4.24% | -17.65% | 49.59% | 12.80% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 321.16% | 43.20% | 22.60% | 65.44% | -152.40% |
| Cash from Investing | -413.48% | -501.60% | 22.65% | 70.67% | -154.10% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -3,266.14% | -2,181.96% | -7.37% | -5.92% | -5.44% |
| Issuance of Common Stock | -26.98% | -78.67% | -60.38% | 68.54% | 164.25% |
| Repurchase of Common Stock | 23.79% | 62.33% | 82.49% | -71.49% | -42.09% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -9.66% | -9.38% | -6.16% | -5.02% | -5.34% |
| Other Financing Activities | 4.24% | 13.76% | 16.72% | 15.91% | 15.16% |
| Cash from Financing | 39.98% | 93.40% | 57.34% | -37.00% | -21.27% |
| Foreign Exchange rate Adjustments | 1,185.71% | 525.81% | -351.35% | 116.79% | 96.32% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -469.70% | -206.20% | 131.99% | 22.96% | -11.90% |